Skip to main content
Erschienen in:

Open Access 24.07.2024 | Original Contributions

Prior Bariatric Surgery Predicts Lower Life-Threatening Morbidity in Patients Admitted for Acute Allergic Reaction and Anaphylaxis: a Propensity Score-Matched Analysis of the U.S. Nationwide Inpatient Sample, 2005–2018

verfasst von: Po-Chun Wang, Wei-Ning Lin

Erschienen in: Obesity Surgery | Ausgabe 9/2024

Abstract

Purpose

Acute allergic reactions may occur in susceptible individuals following exposure to various allergens. Obesity is linked to allergic reactions, and weight loss from bariatric surgery may attenuate the severity of certain conditions such as airway hyperresponsiveness in asthma. This retrospective observational study investigates associations between prior bariatric surgery and lower risk for life-threatening conditions in patients hospitalized with acute allergic reactions and anaphylaxis.

Materials and Methods

Adults ≥ 18 years old diagnosed with morbid obesity and admitted to US hospitals with acute allergic reactions/anaphylaxis were included. All data were extracted from the US Nationwide Inpatient Sample (NIS) database 2005–2018. Patients without information on in-hospital mortality, discharge destination, hospital costs, and length of stay (LOS) were excluded. Patients were divided into two groups based on prior bariatric surgery or not. All diagnoses were verified through ICD-9 and ICD-10 codes. Between-group differences and associations between variables were evaluated using logistic regression analysis.

Results

After matching, patients with prior bariatric surgery had significantly lower proportions of any life-threatening morbidity (37.2% vs. 47.4%), respiratory distress or failure (11.2% vs. 17.0%), pneumonia or severe infection (7.4% vs. 10.2%), sepsis/septic shock (15.2% vs. 20.9%), intubation and mechanical ventilation (11.2% vs. 14.6%), prolonged LOS (10.3% vs. 20.6%) and unfavorable discharge (6.9% vs. 12.5%) than those without prior bariatric surgery.

Conclusion

Prior bariatric surgery predicts a lower risk of life-threatening morbidity and prolonged LOS among adults hospitalized for acute allergic reaction and anaphylaxis. Future prospective studies are warranted to confirm the present findings and reveal underlying mechanisms.

Graphical Abstract

Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s11695-024-07115-6.

Key points

• Bariatric surgery linked to lower acute allergic reaction severity.
• Reduced life-threatening morbidity in post-bariatric surgery patients.
• Lower incidence of respiratory distress and prolonged hospital stays observed.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Acute allergic reactions may occur following exposure to various allergens such as foods, medications, biologic compounds, plants, or venoms, and in a broad range of settings like homes, schools, or hospitals. Reactions are graded on a severity continuum ranging from mild (requiring no or minimal intervention) to anaphylactic shock (requiring treatment with resuscitative therapies) [1]. Acute allergic reactions, including anaphylaxis, place a heavy burden on patients, their families, and the healthcare system. In the US, from 2008 to 2016, more than 400,000 emergency visits were recorded for anaphylaxis alone [2]. Previous studies have reported increasing incidence of severe allergic reactions and anaphylaxis, and symptoms of anaphylaxis may present rapidly, often followed by airway compromise, respiratory distress, hemodynamic instability, and, potentially, death [3].
Recent studies have suggested a link between obesity and allergic reactions, including drug allergies and food allergies, particularly immediate responses [4, 5]. At the same time, strong evidence has verified the efficacy and safety of modern bariatric procedures [6], while also showing that weight loss obtained through bariatric surgery attenuates the severity and adverse outcomes of various diseases, including autoimmune diseases and airway hyperresponsiveness in asthma [710].
Bariatric surgery is associated with a reduced incidence of new diabetes, hypertension, and hypercholesterolemia, ensuring prolonged weight loss and improving patients’ quality of life [11, 12]. Globally, around 580,000 people undergo bariatric surgery annually [13]. The American Society for Metabolic and Bariatric Surgery (ASMBS) estimated that in 2019, more than 256,000 individuals in the United States underwent bariatric surgery [11]. However, to date, no study has evaluated the potential benefits of bariatric surgery in patients admitted for acute allergic reaction and anaphylaxis. We hypothesized that prior bariatric surgery may be associated with a lower risk of life-threatening conditions in patients hospitalized with allergic reactions and anaphylaxis. Therefore, this study aimed to determine the influence of prior bariatric surgery on hospitalization outcomes of patients with acute allergic reactions and anaphylaxis using a large, nationally representative database.

Material and Methods

Study Design and Data Source

This population-based, retrospective observational study extracted all data from the US Nationwide Inpatient Sample (NIS) database, the largest all-payer, continuous inpatient care database in the United States, including about 8 million hospital stays each year (Healthcare Cost and Utilization Project [HCUP]. Introduction to the Nationwide Inpatient Sample [NIS]. Rockville, MD: Agency for Healthcare Research and Quality; 2008.). HCUP, a division of the US National Institutes of Health (NIH) administers the database. Patient data include primary and secondary diagnoses, primary and secondary procedures, admission and discharge status, patient demographics, expected payment source, duration of hospital stay, and hospital characteristics (i.e., bed size/location/teaching status/hospital region). All admitted patients are initially considered for inclusion. The continuous, annually updated NIS database derives patient data from about 1,050 hospitals in 44 states in the US, representing a 20% stratified sample of US community hospitals as defined by the American Hospital Association.

Ethics Statement

All data used in this study were obtained through request to the Online HCUP Central Distributor. This study conforms to the NIS data-use agreement with HCUP. The study was exempted from Institutional Review Board (IRB) approval because there was no direct involvement by patients or other persons as the study used secondary data from the NIS database. Because all data in the NIS database are de-identified, the requirement of informed consent was also waived.

Study Sample Selection

This study utilized the International Classification of Diseases, Ninth Revision (ICD-9) and Tenth (ICD-10) diagnostic codes to identify adults ≥ 18 years old with a diagnosis of morbid obesity (ICD-9: 278.01, V85.35-V85.45; ICD-10: E66.01, Z68.4x) and who were admitted to US hospitals with a primary diagnosis of acute allergic reactions/anaphylaxis between 2005 and 2018 as recorded in the NIS database. The patients were further divided into two groups based on whether or not they had prior bariatric surgery (laparoscopic or open Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and laparoscopic sleeve gastrectomy) through ICD-9 and ICD-10 codes, as shown in previous studies [14]. Patients with no information on in-hospital mortality, discharge destination, hospital costs, and length of stay (LOS) were excluded. The ICD codes for identifying acute allergic reactions/anaphylaxis and bariatric surgery are listed in Supplementary Table 1.

Study Variables and Outcome Measures

Study endpoints were: incidence of 1) any life-threatening morbidity that occurred during admission; 2) in-hospital mortality; 3) unfavorable discharge, defined as transfer to nursing homes or long-term care facilities; 4) prolonged LOS, defined as LOS >  = 75th percentile; and 5) hospital costs. Significant morbidities included cardiac arrest and dysrhythmia, acute myocardial infarction (AMI) and cerebrovascular accident (CVA), venous thromboembolism (VTE), respiratory distress or failure, pneumonia, and severe infection, sepsis and septic shock, and intubation and mechanical ventilation. The ICD codes for identifying these morbidities are listed in Supplementary Table 1.

Covariates

Patients’ demographic characteristics included age, sex, race, household income, and insurance status (primary payer). Clinical characteristics included significant comorbidities (i.e., coronary artery disease, congestive heart failure, diabetes, hypertension, cerebrovascular disease, chronic respiratory disease, rheumatic disease, and renal insufficiency), which were identified using ICD codes. Hospital-related characteristics (bed size, location/teaching status, hospital region) were also extracted from the database as part of the comprehensive data available for all participants.

Statistical Analysis

All analyses were performed using SAS survey statements to address the complex sampling design for HCUP-NIS data (SAS Institute Inc., Cary, NC, USA). Continuous variables are presented as weighted mean and standard error (SE); categorical variables are presented as unweighted numbers and weighted proportions. Differences in means between the groups were compared using the SURVEYREG statement for continuous variables. Rao-Scott chi-square test was performed to examine differences in proportions between the groups using the SURVEYFREQ statement for categorical variables. Logistic regression was conducted using the SURVEYLOGISTIC statement to determine the associations between study variables and outcomes of interest. To balance the baseline characteristics between the groups (prior bariatric surgery or not), patients in the two groups were propensity score-matched (PSM). Propensity scores assigned to each patient were derived from the multivariable logistic regression model constructed to determine the likelihood of receiving bariatric surgery after controlling variables with a p-value < 0.01 in the unmatched population of the two groups. A 1:4 fixed ratio nearest-neighbor matching was performed. Further, univariate and multivariate logistic regression models were used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) in estimating the associations between study variables and patient outcomes. Variables that reached statistical significance in univariate analysis were included in multivariate models after adjusting for possible confounding variables. A two-sided P-value of < 0.05 was regarded as statistical significance.

Results

Study Sample

The study sample selection process is depicted in Fig. 1. A total of 21,561 hospitalized patients aged ≧18 diagnosed with morbid obesity and admitted to hospitals for acute allergic reactions and anaphylaxis were identified in the HCUP-NIS database of the US from 2005 to 2018. After excluding patients with missing information on LOS, discharge destination, in-hospital mortality, or hospital costs, 21,126 patients (representing a 105,056 US population) were finally included. Among these, 683 patients had undergone bariatric surgery, and 2,732 patients were not retained for subsequent analyses after 1:4 ratio PSM. Proportions of each primary diagnosis of acute allergic reaction and anaphylaxis are listed in Supplementary Table 2.

Characteristics of Patients Hospitalized for Acute Allergic Reaction and Anaphylaxis

Supplementary Table 3 summarizes the characteristics of patients hospitalized for acute allergic reaction and anaphylaxis before PSM. The mean age of the Patients’ mean age was 54.7 ± 0.1 years, and females accounted for 67.5%. Significant differences were found between patients with or without prior bariatric surgery in age, sex, race, income, primary payer, some comorbidities (all p < 0.01), and hospital location. Patients with prior bariatric surgery were younger, with more females, and had fewer comorbidities than those without bariatric surgery. After PSM, the different initial distributions in the characteristics of patients and hospital between the two groups were balanced, as shown in Table 1.
Table 1
Characteristics of patients hospitalized for acute allergic reaction and anaphylaxis, after matching
 
Overall (N = 16989)
(n = 3415)
No prior bariatric surgery (n = 2732)
With prior bariatric surgery (n = 683)
p-value
Age
50.7 ± 0.2
51.0 ± 0.2
49.6 ± 0.5
0.017
  18–29
160 (4.7)
119 (4.4)
41 (6.1)
0.105
  30–39
584 (17.1)
458 (16.8)
126 (18.3)
 
  40–49
835 (24.5)
682 (25.0)
153 (22.5)
 
  50–59
893 (26.1)
704 (22.0)
189 (27.8)
 
  60–59
737 (21.6)
599 (22.0)
138 (20.1)
 
  70 + 
206 (6.0)
170 (6.2)
36 (5.2)
 
Sex
  Male
638 (18.6)
509 (18.6)
129 (18.8)
0.869
  Female
2777 (81.4)
2223 (81.4)
554 (81.2)
 
Race
  White
2511 (73.6)
2021 (74.1)
490 (72.0)
0.645
  Black
591 (17.3)
463 (16.9)
128 (18.6)
 
  Hispanic
217 (6.3)
170 (6.2)
47 (6.7)
 
  Others
96 (2.8)
78 (2.8)
18 (2.6)
 
Household income
  Q1
931 (27.2)
740 (27.0)
191 (28.2)
0.903
  Q2
926 (27.2)
742 (27.3)
184 (26.9)
 
  Q3
913 (26.7)
735 (26.9)
178 (25.9)
 
  Q4
645 (18.9)
515 (18.8)
130 (19.0)
 
Primary payer
  Medicare/Medicaid
1486 (43.4)
1200 (43.9)
286 (41.7)
0.129
  Private including HMO
1735 (50.9)
1387 (50.8)
348 (51.1)
 
  Self-pay/no charge/others
194 (5.7)
145 (5.3)
49 (7.2)
 
Admission type
  Elective
1211 (35.5)
964 (35.4)
247 (36.2)
0.708
  Emergent
2204 (64.5)
1768 (64.6)
436 (63.8)
 
Comorbidities
  CAD
308 (9.0)
248 (9.1)
60 (8.7)
0.756
  Diabetes
1283 (37.5)
1032 (37.7)
251 (36.7)
0.590
  Hypertension
1975 (57.9)
1583 (58.0)
392 (57.3)
0.745
  Cerebrovascular disease
83 (2.4)
65 (2.4)
18 (2.6)
0.696
  Chronic respiratory disease
1123 (32.9)
889 (32.5)
234 (34.2)
0.374
  Rheumatic disease
106 (3.1)
88 (3.2)
18 (2.6)
0.381
  Renal insufficiency
257 (7.5)
203 (7.4)
54 (7.9)
0.647
Hospital bedsize
  Large
1818 (57.9)
1458 (53.3)
360 (52.7)
0.965
  Medium
1221 (35.7)
795 (29.2)
200 (29.4)
 
  Small
218 (6.4)
479 (17.5)
123 (17.8)
 
Location/teaching status
  Urban teaching
1976 (57.9)
1591 (58.3)
385 (56.2)
0.578
  Urban nonteaching
1221 (35.7)
968 (35.4)
253 (37.0)
 
  Rural
218 (6.4)
173 (68.3)
45 (6.8)
 
Hospital region
  Northeast
562 (16.6)
432 (16.0)
130 (19.0)
0.345
  Midwest
859 (25.2)
689 (25.2)
170 (25.1)
 
  South
1432 (41.9)
116 (42.3)
276 (40.3)
 
  West
562 (16.3)
455 (16.5)
107 (15.6)
 
Continuous data are presented as mean ± SE; categorical data are presented as unweighted count (weighted %)
CAD coronary artery disease, HMO Health Maintenance Organization

Outcomes of Patients Hospitalized for Acute Allergic Reaction and Anaphylaxis

Frequencies of outcomes among patients hospitalized for acute allergic reaction and anaphylaxis are listed in Table 2 and Supplemental Table 4. After matching, patients with prior bariatric surgery had a significantly lower proportion of any life-threatening morbidity (37.2% vs 47.4%), respiratory distress and failure (11.2% vs 17.0%), pneumonia and severe infection (7.4% vs 10.2%), sepsis and septic shock (15.2% vs 20.9%), intubation and mechanical ventilation (11.2% vs 14.6%), prolonged LOS (10.3% vs 20.6%) and unfavorable discharge (6.9% vs 12.5%) than those without prior bariatric surgery, respectively.
Table 2
Outcomes of patients hospitalized for acute allergic reaction and anaphylaxis, after matching
 
After matching (n = 3415)
 
No prior bariatric surgery (n = 2732)
With prior bariatric surgery (n = 683)
p-value
Any life-threatening morbidity
1296 (47.4)
254 (37.2)
 < 0.001
  Cardiac arrest and dysrhythmia
281 (10.3)
54 (7.9)
0.056
  AMI and CVA
91 (3.3)
19 (2.8)
0.399
  VTE
122 (4.5)
22 (3.5)
0.190
  Respiratory distress and failure
464 (17.0)
76 (11.2)
 < 0.001
  Pneumonia and severe infection
279 (10.2)
51 (7.4)
0.019
  Sepsis and septic shock
571 (20.9)
104 (15.2)
 < 0.001
  Intubation and mechanical ventilation
400 (14.6)
77 (11.2)
0.017
Prolonged LOS
557 (20.6)
71 (10.3)
 < 0.001
Unfavorable discharge
338 (12.5)
47 (6.9)
 < 0.001
Mortality
29 (1.1)
3 (0.4)
0.129
Hospital cost
57,950 ± 1652.0
51,343 ± 2839.9
0.055
Continuous data are presented as mean ± SE; categorical data are presented as unweighted count (weighted %)
AMI acute myocardial infarction, CVA cerebrovascular accident, VTE venous thromboembolism, LOS length of stay

Prior Bariatric Surgery and Outcomes in Patients Hospitalized for Acute Allergic Reaction and Anaphylaxis

A multivariable regression model was constructed to determine the associations between inpatient outcomes and prior bariatric surgery. The results are shown in Table 3. After adjusting for relevant confounders, patients who had prior bariatric surgery were significantly less likely to have life-threatening morbidity during hospitalization than those who had not (aOR:0.64, 95% CI:0.54–0.76). Also, patients with prior bariatric surgery had a significantly lower risk for prolonged LOS (aOR: 0.43, 95% CI:0.33–0.55). However, prior bariatric surgery was not associated with reduced odds of significant mortality or unfavorable discharge. Regarding individual morbidities, significantly lower odds were found in respiratory distress and failure (aOR: 0.61, 95% CI:0.47–0.78), pneumonia and severe infection (aOR: 0.71, 95% CI:0.53–0.96), sepsis and septic shock (aOR: 0.69, 95% CI:0.55–0.85), and intubation and mechanical ventilation (aOR: 0.72, 95% CI:0.56–0.93) in patients with prior bariatric surgery compared to those without prior bariatric surgery.
Table 3
Multivariate analysis of associations between prior bariatric surgery and inpatient outcomes
 
With prior bariatric surgery (vs No prior bariatric surgery)
aOR (95% CI)
Any life-threatening morbidity
0.64 (0.54–0.76)
  Cardiac arrest and dysrhythmia
0.75 (0.56–1.02)
  AMI and CVA
0.57 (0.30–1.08)
  VTE
0.76 (0.51–1.14)
  Respiratory distress and failure
0.61 (0.47–0.78)
  Pneumonia and severe infection
0.71 (0.53–0.96)
  Sepsis and septic shock
0.69 (0.55–0.85)
  Intubation and mechanical ventilation
0.72 (0.56–0.93)
Prolonged LOS
0.43 (0.33–0.55)
Unfavorable discharge
0.51 (0.38–3.55)
Mortality
0.41 (0.12–1.39)
AMI, acute myocardial infarction; CAD, coronary artery disease; CVA, cerebrovascular accident; VTE, venous thromboembolism; LOS, length of stay
Multivariate models adjusted for:
Any morbidity: age, sex, race, primary payer, admission type, CAD, diabetes, cerebrovascular disease, chronic respiratory disease, renal insufficiency, location/teaching status
Cardiac arrest or dysrhythmia: age, sex, race, CAD, diabetes, hypertension, location/teaching status
AMI and CVA: age, sex, admission type, CAD, cerebrovascular disease, hospital bed size, location/teaching status
VTE: admission type, diabetes, hypertension
Respiratory distress and failure: age, sex, household income, primary payer, admission type, CAD, diabetes, cerebrovascular disease, chronic respiratory disease, renal insufficiency
Pneumonia and severe infection: age, sex, race, primary payer, admission type, hypertension, renal insufficiency
Sepsis and septic shock: age, sex, race, household income, admission type, CAD, diabetes, renal insufficiency, hospital bed size, location/teaching status, hospital region
Intubation and mechanical ventilation: age, gender, race, admission type, CAD, diabetes, cerebrovascular disease, chronic respiratory disease, renal insufficiency, hospital region
Prolonged LOS: age, primary payer, admission type, CAD, diabetes, cerebrovascular disease, renal insufficiency, hospital bed size
Unfavorable discharge: age, primary payer, diabetes, cerebrovascular disease, rheumatic disease, renal insufficiency, hospital bed size
Mortality: age, race, primary payer, CAD, cerebrovascular disease

Discussion

The present study demonstrated that prior bariatric surgery is independently and significantly associated with a 36% lowered risk for any life-threatening morbidity and a 57% reduced risk for prolonged LOS in patients hospitalized for acute allergic reaction and anaphylaxis compared to those who did not undergo prior bariatric surgery. Lower risk was also observed for respiratory distress and failure, pneumonia and severe infection, sepsis and septic shock, and intubation and mechanical ventilation among patients who received prior bariatric surgery versus those who did not. To the best of our knowledge, the present study is the first to report the impact of bariatric surgery on outcomes after hospitalization for acute allergic reaction.
Anaphylaxis is classically defined as an allergen-driven process that induces specific IgE and activation of mast cells and basophils through cross-linking IgE receptors. However, it is also known that non-IgE-mediated pathways cause symptoms indistinguishable from those of classic anaphylaxis, and their activation may explain the severity of IgE-mediated anaphylaxis [15, 16]. A previous study demonstrated that obesity is a risk factor for neuromuscular blocking agent anaphylaxis, with risk increasing as body mass index (BMI) increases [17]. That result supports findings in the present study that weight loss from prior bariatric surgery in patients hospitalized for acute allergic reaction and anaphylaxis is associated with a lower risk for any life-threatening morbidity and prolonged LOS. Together, these results suggest that patients with a history of acute allergic reactions and anaphylaxis need strict control of weight, whether or not they have undergone bariatric surgery.
Although results of the present study indicate that patients with prior bariatric surgery are less likely to have life-threatening morbidity and prolonged LOS, the mechanism underlying the protective effect of bariatric surgery on outcomes of hospitalization for acute allergic reaction is unclear. A previous review article suggested that adipocytes, which store excess fuel in lipid vacuoles, may hypertrophy and eventually rupture, releasing internal contents that induce inflammatory processes [18]. Fat infiltrates adipose tissue and finds its way into the liver, skeletal muscle, pancreas, and other metabolically relevant organs; therefore, infiltrating adipose tissue into these organs results in local production of adipokines and pro-inflammatory cytokines. As adipose tissue organs expand with the infiltration of fat, the specific adipokines are produced and released into circulation at a higher rate, causing inflammation in other organ systems. Another study explained the link between obesity and food allergies based on the pro-inflammatory immunological effects of adipose tissue in obesity [19]. Consistent with the present research, a previous paper demonstrated that obese individuals had elevated total serum eosinophils and high IgE levels [20]. At the same time, in most people, anaphylaxis is caused by the presence of IgE to a specific allergen. Therefore, weight loss through bariatric surgery may reduce the severity of anaphylaxis through lowered circulating IgE levels.

Strengths and Limitations

The present study is strengthened by the use of a large sample representing a nationwide population. The extended study period across 13 years also adds credence to the findings. PSM was also applied to minimize confounding of measured variables. However, this study is inherently limited by its retrospective and observational nature, which may limit the measurement of certain variables and generalization of findings to other populations. Selection bias also cannot be ruled out and the defined time periods in the database do not include follow-up data after discharge. Possible coding errors may have occurred as in other studies that used ICD code systems. Furthermore, we were unable to obtain data on patients’ responses to bariatric surgery, such as exact BMI changes and weight loss proportions, potentially limits further inference drawn from the analytical results. The precise severity of acute allergic reactions and comorbidities could not be distinguished because of insufficient data in the NIS. Medications prescribed were also not recorded in the database so these data could not be analyzed.

Conclusions

Prior bariatric surgery predicts a lower risk of any life-threatening morbidity and prolonged LOS among adults hospitalized for acute allergic reaction and anaphylaxis. Further prospective studies incorporating measurements of exact weight loss following bariatric surgery remain necessary to substantiate the findings, and delve into the underlying mechanisms that elucidate the beneficial effects bariatric surgery within this patient population.

Declarations

Ethical Approval

For this type of study formal consent is not required.
Informed Consent does not apply.

Competing Interests

The authors have declared that no competing interests exist.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

e.Med Interdisziplinär

Kombi-Abonnement

© Springer Medizin

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Dribin TE, Schnadower D, Spergel JM, et al. Severity grading system for acute allergic reactions: a multidisciplinary Delphi study. J Allergy Clin Immunol. 2021;148(1):173–81.CrossRefPubMedPubMedCentral Dribin TE, Schnadower D, Spergel JM, et al. Severity grading system for acute allergic reactions: a multidisciplinary Delphi study. J Allergy Clin Immunol. 2021;148(1):173–81.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Michelson KA, Dribin TE, Vyles D, et al. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(2):767-768.e762.CrossRefPubMed Michelson KA, Dribin TE, Vyles D, et al. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(2):767-768.e762.CrossRefPubMed
3.
Zurück zum Zitat Shrestha P, Dhital R, Poudel D, et al. Trends in hospitalizations related to anaphylaxis, angioedema, and urticaria in the United States. Ann Allergy Asthma Immunol. 2019;122(4):401-406.e402.CrossRefPubMed Shrestha P, Dhital R, Poudel D, et al. Trends in hospitalizations related to anaphylaxis, angioedema, and urticaria in the United States. Ann Allergy Asthma Immunol. 2019;122(4):401-406.e402.CrossRefPubMed
4.
Zurück zum Zitat Dias de Castro E, Pinhão S, Paredes S, et al. Obesity markers in patients with drug allergy and body fat as a predictor. Ann Allergy Asthma Immunol. 2021;127(1):100–8.CrossRefPubMed Dias de Castro E, Pinhão S, Paredes S, et al. Obesity markers in patients with drug allergy and body fat as a predictor. Ann Allergy Asthma Immunol. 2021;127(1):100–8.CrossRefPubMed
5.
Zurück zum Zitat Hayashi K, Tsujiguchi H, Hori D, et al. The association between overweight and prevalence of food allergy in Japanese children: a cross-sectional study. Environ Health Prev Med. 2021;26(1):44.CrossRefPubMedPubMedCentral Hayashi K, Tsujiguchi H, Hori D, et al. The association between overweight and prevalence of food allergy in Japanese children: a cross-sectional study. Environ Health Prev Med. 2021;26(1):44.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.CrossRefPubMed Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.CrossRefPubMed
7.
Zurück zum Zitat Biobaku F, Ghanim H, Monte SV, et al. Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects. J Endocr Soc. 2020;4(9):bvaa049.CrossRefPubMedPubMedCentral Biobaku F, Ghanim H, Monte SV, et al. Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects. J Endocr Soc. 2020;4(9):bvaa049.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hossain N, Arhi C, Borg CM. Is bariatric surgery better than nonsurgical weight loss for improving asthma control? A systematic review. Obes Surg. 2021;31(4):1810–32.CrossRefPubMed Hossain N, Arhi C, Borg CM. Is bariatric surgery better than nonsurgical weight loss for improving asthma control? A systematic review. Obes Surg. 2021;31(4):1810–32.CrossRefPubMed
10.
Zurück zum Zitat Lespessailles E, Hammoud E, Toumi H, et al. Consequences of bariatric surgery on outcomes in rheumatic diseases. Arthritis Res Ther. 2019;21(1):83.CrossRefPubMedPubMedCentral Lespessailles E, Hammoud E, Toumi H, et al. Consequences of bariatric surgery on outcomes in rheumatic diseases. Arthritis Res Ther. 2019;21(1):83.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Booth H, Khan O, Prevost T, et al. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. Lancet Diabetes Endocrinol. 2014;2(12):963–8.CrossRefPubMed Booth H, Khan O, Prevost T, et al. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. Lancet Diabetes Endocrinol. 2014;2(12):963–8.CrossRefPubMed
12.
Zurück zum Zitat Wiggins T, Guidozzi N, Welbourn R, et al. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Med. 2020;17(7): e1003206.CrossRefPubMedPubMedCentral Wiggins T, Guidozzi N, Welbourn R, et al. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Med. 2020;17(7): e1003206.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017;27(9):2279–89.CrossRefPubMedPubMedCentral Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017;27(9):2279–89.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Sharma P, McCarty TR, Yadav S, et al. Impact of bariatric surgery on outcomes of patients with sickle cell disease: a nationwide inpatient sample analysis, 2004–2014. Obes Surg. 2019;29(6):1789–96.CrossRefPubMed Sharma P, McCarty TR, Yadav S, et al. Impact of bariatric surgery on outcomes of patients with sickle cell disease: a nationwide inpatient sample analysis, 2004–2014. Obes Surg. 2019;29(6):1789–96.CrossRefPubMed
15.
Zurück zum Zitat Nguyen SMT, Rupprecht CP, Haque A, et al. Mechanisms governing anaphylaxis: inflammatory cells, mediators, endothelial gap junctions and beyond. Int J Mol Sci. 2021;22(15):7785.CrossRefPubMedPubMedCentral Nguyen SMT, Rupprecht CP, Haque A, et al. Mechanisms governing anaphylaxis: inflammatory cells, mediators, endothelial gap junctions and beyond. Int J Mol Sci. 2021;22(15):7785.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Sadleir PHM, Clarke RC, Goddard CE, et al. Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study. Br J Anaesth. 2021;126(5):940–8.CrossRefPubMed Sadleir PHM, Clarke RC, Goddard CE, et al. Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study. Br J Anaesth. 2021;126(5):940–8.CrossRefPubMed
18.
Zurück zum Zitat Phillips CL, Grayson BE. The immune remodel: Weight loss-mediated inflammatory changes to obesity. Exp Biol Med (Maywood). 2020;245(2):109–21.CrossRefPubMed Phillips CL, Grayson BE. The immune remodel: Weight loss-mediated inflammatory changes to obesity. Exp Biol Med (Maywood). 2020;245(2):109–21.CrossRefPubMed
19.
Zurück zum Zitat Guo X, Cheng L, Yang S, et al. Pro-inflammatory immunological effects of adipose tissue and risk of food allergy in obesity: Focus on immunological mechanisms. Allergol Immunopathol (Madr). 2020;48(3):306–12.CrossRefPubMed Guo X, Cheng L, Yang S, et al. Pro-inflammatory immunological effects of adipose tissue and risk of food allergy in obesity: Focus on immunological mechanisms. Allergol Immunopathol (Madr). 2020;48(3):306–12.CrossRefPubMed
20.
Zurück zum Zitat Holguin F, Bleecker ER, Busse WW, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011;127(6):1486-1493.e1482.CrossRefPubMedPubMedCentral Holguin F, Bleecker ER, Busse WW, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011;127(6):1486-1493.e1482.CrossRefPubMedPubMedCentral
Metadaten
Titel
Prior Bariatric Surgery Predicts Lower Life-Threatening Morbidity in Patients Admitted for Acute Allergic Reaction and Anaphylaxis: a Propensity Score-Matched Analysis of the U.S. Nationwide Inpatient Sample, 2005–2018
verfasst von
Po-Chun Wang
Wei-Ning Lin
Publikationsdatum
24.07.2024
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 9/2024
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-024-07115-6

Weitere Artikel der Ausgabe 9/2024

Obesity Surgery 9/2024 Zur Ausgabe

Neu im Fachgebiet Chirurgie

Vorschau auf die zukünftige S3-Leitlinie zum kolorektalen Karzinom

Die S3-Leitlinie zum Management des kolorektalen Karzinoms (KRK) stammt in ihrer aktuellen Version noch aus dem Jahr 2017. Die Aktualisierung läuft.

Zöliakie? Das kostet!

Nach der Diagnose Zöliakie steigen die Kosten und der Ressourcenbedarf im Gesundheitswesen erheblich an.

MASLD und MASH: Neue Nomenklatur und neue Therapien

Nach der neuen Nomenklatur der Fettlebererkrankungen haben die europäischen Fachgesellschaften EASL, EASD und EASO auch die Empfehlungen zum Management der mit einer metabolischen Dysfunktion assoziierten steatotischen Lebererkrankung (MASLD) aktualisiert.

Proteine allein reichen nach bariatrischer Op. nicht für Muskelerhalt

Nach bariatrischer Operation soll nicht nur eine Malnutrition, sondern auch eine Sarkopenie verhindert werden. Empfohlen wird eine hohe Proteinzufuhr. Das alleine erhält die Muskelmasse und  -funktion nicht.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.